Email alerts
Advanced Search
  • May 25, 2010
    Record Fourth Quarter Caps Strong Year for Medtronic
    International Revenue Growth of 20 Percent

    MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...

  • May 25, 2010
    Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve(R) Transcatheter Aortic Valve System
    Data Demonstrates That Revolutionary Treatment for Patients with Diseased Heart Valves Is Transitioning Successfully into Standard Clinical Practice throughout Europe

    PARIS, May 25, 2010 (BUSINESS WIRE) --New European data from five national clinical registries presented today at EuroPCR report positive clinical outcomes for one of the most exciting emerging...

  • May 25, 2010
    Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
    One-Year Clinical Results from Innovative RESOLUTE All Comers Trial Show Excellent Performance for Resolute DES in Challenging Patient Population

    PARIS, May 25, 2010 (BUSINESS WIRE) --The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR...

  • May 20, 2010
    Medtronic Announces 2010 Analyst Meeting and Webcast
    Medtronic Institutional Investor and Analyst Meeting Scheduled for Monday, June 7, 2010, 10 a.m. - 2:30 p.m. Eastern

    MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 7, 2010, in New York City from 10 a.m. - 2:30 p.m. Eastern...

  • May 20, 2010
    Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR
    Cardiology Meeting in Paris May 25-28 Includes New Data on Resolute(R) Drug-Eluting Stent, IN.PACT Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

    MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking...

Show 5102550100 per page